Results 31 to 40 of about 98,491 (346)

High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India [PDF]

Intestinal Research, 2018
Background/Aims The data on the risk of tuberculosis (TB) reactivation with infliximab (IFX) in patients with inflammatory bowel disease (IBD) from TB endemic countries, like India, is limited.
Ashish Agarwal, Saurabh Kedia, Saransh Jain, Vipin Gupta, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Venigalla Pratap Mouli, Rajan Dhingra, Govind Makharia, Vineet Ahuja   +10 more
doaj   +1 more source

Tricks to translating TB transcriptomics. [PDF]

, 2015
Transcriptomics and other high-throughput methods are increasingly applied to questions relating to tuberculosis (TB) pathogenesis. Whole blood transcriptomics has repeatedly been applied to define correlates of TB risk and has produced new insight into ...
Coussens, AK, Deffur, A, Wilkinson, RJ
core   +1 more source

Development and evaluation of a diagnostic cytokine-release assay for Mycobacterium suricattae infection in meerkats (Suricata suricatta) [PDF]

, 2017
CITATION: Clarke, C., et al. 2017. Development and evaluation of a diagnostic cytokine-release assay for mycobacterium suricattae infection in meerkats (Suricata suricatta).
A Dippenaar, C Clarke, Charlene Clarke, I Schiller, JA Drewe, JA Drewe, JA Drewe, Julian Ashley Drewe, KA Millington, KE Bass, M Ruhwald, Michele Ann Miller, MP Petticrew, NN Chegou, Paul David van Helden, R Rua-Domenech de la, SDC Parsons, SDC Parsons, Stuart James Patterson, Sven David Charles Parsons, TH Clutton-Brock, WJ Goosen, WJ Goosen   +22 more
core   +3 more sources

Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence

Pulmonary Medicine, 2013
A profusion of articles have been published on the accuracy and uses of interferon-gamma releasing assays. Here we review the clinical applications, advantages, and limitations of the tuberculin skin test and interferon-gamma release assays and provide ...
A. Trajman, R. E. Steffen, D. Menzies
doaj   +1 more source

Tuberculosis in Children: New diagnostic Blood Tests

Canadian Journal of Infectious Diseases and Medical Microbiology, 2010
The interferon-gamma-release assays were developed to overcome the pitfalls and logistic difficulties of the tuberculin skin test (TST) for the diagnosis of latent tuberculosis infection (LTBI).
F Kakkar, UD Allen, D Ling, M Pai, IC Kitai   +4 more
doaj   +1 more source

Chest roentgenography is complementary to interferon-gamma release assay in latent tuberculosis infection screening of rheumatic patients

BMC Pulmonary Medicine, 2020
Background A study of latent tuberculosis infection (LTBI) burden by chest roentgenography (CXR) with reference to interferon-gamma release assay (IGRA) is still lacking in rheumatic patients of an intermediate tuberculosis burden area.
Ping-Huai Wang, Chou-Han Lin, Ting-Hui Chang, Chien-Sheng Wu   +3 more
semanticscholar   +1 more source

Interferon-gamma-release assays: Better than tuberculin skin testing?

Cleveland Clinic Journal of Medicine, 2010
Although the tuberculin skin test has long been the standard for detecting latent tuberculosis infection, it has many limitations. Interferon-gamma-release assays are gaining acceptance as an alternative. In this paper we present cases to illustrate how these new tests can be used and how to interpret the results.
Cyndee, Miranda, J Walton, Tomford, Steven M, Gordon   +2 more
openaire   +2 more sources

Screening for Tuberculosis in Health Care Workers. Experience in an Italian Teaching Hospital [PDF]

, 2017
Health care workers (HCW) are particularly at risk of acquiring tuberculosis (TB), even in countries with low TB incidence. Therefore, TB screening in HCW is a useful prevention strategy in countries with both low and high TB incidence.
De Luca, Assunta, DI NINNO, Filippo, Ferretti, Filippo, Marani, Alessandra, Napoli, Christian, Orioli, Riccardo, Orsi, Giovanni Battista, Prestigiacomo, Claudio, Sarlo, MARIA GIUDITTA   +8 more
core   +3 more sources

In Vitro Release of Interferon-Gamma from Peripheral Blood Lymphocytes in Cutaneous Adverse Drug Reactions

Clinical and Developmental Immunology, 2012
Background. Cutaneous drug reactions are common but diagnostically challenging due to phenotypic heterogeneity and simultaneous exposure to multiple drugs. These limitations prompted the development of diagnostic tests. Aims.
Ilan Goldberg, Meital Hanson, Gabriel Chodick, Idit Shirazi, Sarah Brenner   +4 more
doaj   +1 more source

Agreement between the results of tuberculin skin test and Interferon-Gamma Release Assays in renal transplant candidates

Journal of Research in Medical Sciences, 2021
Introduction: Identification of latent tuberculosis (TB) infection is important in kidney transplant candidates. Due to the absence of a gold standard, both tuberculin skin test (TST) and interferon-gamma release assays (IGRA) are used to screen patients.
Shiva Samavat, Sam Alahyari, Ali Sangian, Malihe Nasiri, Mohsen Nafar, Ahmad Firoozan, Fariba Samadian, Nooshin Dalili, Fatemeh Poorrezagholi   +8 more
doaj   +1 more source